S

Simcere Pharmaceutical

Chinese pharmaceutical company

Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate.

Nº Q7517459 ★★★

Rara · Organizações

Simcere Pharmaceutical

Chinese pharmaceutical company

Texto em inglês

Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate.

Último preço

—

Preço mínimo

—

Mediana 7 d

—

Vendas 30 d

0

Faixa 30 d

—

Em circulação

0

Cotação

Ver tabela
Datamediana MínMáxvendas

Histórico de vendas

Última venda
—
Média 30 d
—
Mínima 30 d
—
Máxima 30 d
—
Vendas 7 d
0
Vendas 30 d
0

Ainda sem vendas.

Vendas anônimas: sem comprador nem vendedor. Os números contam só vendas entre jogadores.

№ Edições numeradas · 0 cunhadas Próximo n.º 1 · Pontos ×3
Na Wikipédia

Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.

Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration (SFDA) to manufacture and sell over 210 other products.

Texto: Wikipédia em inglês, CC BY-SA 4.0. ·

Cartas próximas

Ver a ficha

Confirmação